CompletedPhase 1NCT00003867
Irinotecan and Capecitabine in Treating Patients With Solid Tumors
Studying Adenocarcinoma of the anal canal
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Montefiore Medical Center
- Principal Investigator
- Sridhar Mani, MDAlbert Einstein College of Medicine
- Intervention
- capecitabine(drug)
- Enrollment
- 30 enrolled
- Eligibility
- 18-120 years · All sexes
- Timeline
- 1999 – 2003
Study locations (1)
- Albert Einstein Comprehensive Cancer Center, The Bronx, New York, United States
Collaborators
National Cancer Institute (NCI)
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00003867 on ClinicalTrials.govOther trials for Adenocarcinoma of the anal canal
Additional recruiting or active studies for the same condition.